Benign prostatic hyperplasia: -Improvement of symptoms of benign prostatic hyperplasia -Degeneration of the enlarged prostate and improvement of urinary flow -Reduced frequency of acute urinary retention -Reduced need for surgery including Transurethral Resection of the Prostate and prostatectomy surgery
2) Usage, dosage
Finasteride is administered orally at 5 mg once a day, regardless of meal. -Even if symptoms improve upon taking this medication, treatment for at least 6 months is required. - Patients with renal failure: From a pharmacokinetic point of view, there was no change when administering this drug, so it can be used in various types of renal failure patients There is no need to adjust the dose (reatinine clearance rate: 9.0mL/min). -Elderly: In elderly people over 70 years of age, there is no need to adjust the dose, although excretion of this drug is slightly reduced.
3) Packaging unit
30 tablets/PTP (10 tablets/PTP×3)
4) Ingredients, content
Finasteride 5 milligrams
5) Period of use
36 months from date of manufacture
6) Storage method
Store in airtight container at room temperature (1-30°C).
